{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:52:10Z","timestamp":1791993130941,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007141","name":"Anti-Doping Laboratory Qatar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jpba.2024.116007","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:04:21Z","timestamp":1706918661000},"page":"116007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Liquid vs dried blood matrices: Application to longitudinal monitoring of androstenedione, testosterone, and IGF-1 by LC\u2013MS-based techniques"],"prefix":"10.1016","volume":"242","author":[{"given":"Monica","family":"Mazzarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Al-Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Khalid","family":"Al-Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AlAnoud","family":"Al-Kaabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waseem","family":"Samsam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Kraiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Botr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Beotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Mohamed-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Maadheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116007_bib1","unstructured":"The World Anti-Doping Code. The 2023 Prohibited List International Standard. World Anti-Doping Agency, Montreal, Canada. Available at: \u3008www.wada-ama.org\u3009. Accessed 17 January 2023."},{"key":"10.1016\/j.jpba.2024.116007_bib2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1373\/clinchem.2011.162271","article-title":"The Athletes Biological Passport","volume":"57","author":"Sottas","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2024.116007_bib3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1476-5381.2011.01822.x","article-title":"The evolving science of detection of \u2018blood doping\u2019","volume":"165","author":"Lundby","year":"2012","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.jpba.2024.116007_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/dta.406","article-title":"Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport","volume":"4","author":"Schumacher","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100632","article-title":"Blood doping: then and now. A narrative review of the history, science and efficacy of blood doping in elite sport","volume":"39","author":"Atkinson","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.jpba.2024.116007_bib6","doi-asserted-by":"crossref","unstructured":"Krumm B., Saugy J.J., Botr\u00e8 F., Donati F., Faiss R. Indirect biomarkers of blood doping: A systematic review. 2023 https:77doi.org\/10.1002\/dta-3514.","DOI":"10.1002\/dta.3514"},{"key":"10.1016\/j.jpba.2024.116007_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/dta.2790","article-title":"Do dried blood spots (DBS) have the potential to support result management processes in routine sports drug testing?","volume":"12","author":"Thevis","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/dta.3011","article-title":"Do dried blood spots have the potential to support result management processes in routine sports drug testing?\u2014part 2: proactive sampling for follow-up investigations concerning atypical or adverse analytical findings","volume":"13","author":"Thevis","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpba.2016.03.055","article-title":"Sport drug testing using complementary matrices: advantages and limitations","volume":"130","author":"Thevis","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12020-014-0185-2","article-title":"Acute effects of physical exercise and phosphodiesterase\u2019s type 5 inhibition on serum 11\u03b2-hydroxysteroid dehydrogenases related glucocorticoids metabolites: a pilot study","volume":"47","author":"Di Luigi","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.jpba.2024.116007_bib11","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00216-015-9185-1","article-title":"Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS\/MS as a tool to detect testosterone abuse in sports","volume":"408","author":"Ponzetto","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116007_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coemr.2019.05.006","article-title":"Steroidal module of the Athlete Biological Passport","volume":"9","author":"Ponzetto","year":"2019","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"11\u201312","key":"10.1016\/j.jpba.2024.116007_bib13","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/dta.3382","article-title":"Comparison of three different blood matrices for the quantification of endogenous steroids using UHPLC-MS\/MS","volume":"14","author":"Salamin","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00216-012-6626-y","article-title":"Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport","volume":"405","author":"Cox","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2024.116007_bib15","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4155\/bio.14.109","article-title":"Sensitive quantification of IGF-1 and its synthetic analogs in dried blood spots","volume":"6","author":"Cox","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2024.116007_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4155\/bio-2020-0013","article-title":"Use of capillary dried blood for quantification of intact IGF-I by LC\u2013HRMS for antidoping analysis","volume":"12","author":"Mongongu","year":"2020","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2024.116007_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115274","article-title":"Capillary blood as a complementary matrix for doping control purpose. Application to the definition of the individual longitudinal profile of IGF-1.","volume":"227","author":"Stacchini","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4155\/bio-2021-0019","article-title":"Dried blood spots in doping analysis","volume":"13","author":"Yuan","year":"2021","journal-title":"Bioanalysis"},{"issue":"36","key":"10.1016\/j.jpba.2024.116007_bib19","doi-asserted-by":"crossref","first-page":"31845","DOI":"10.1021\/acsomega.2c01417","article-title":"UHPLC-HRMS method for the simultaneous screening of 235 drugs in capillary blood for doping control purpose: comparative evaluation of volumetric and non-volumetric dried blood spotting devices","author":"Mazzarino","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2024.116007_bib20","unstructured":"World Anti-Doping Agency. WADA Technical Document-TD2021DBS-Requirements and Procedures for Collection, Transport, Analytical Testing and Storage. \u3008http:\/\/www.wadaama.org\u3009. (Last accessed 17 January 2022)."},{"key":"10.1016\/j.jpba.2024.116007_bib21","unstructured":"World Anti-Doping Agency. WADA Technical Document-TD2023DBS-Requirements and Procedures for Analytical Testing and Storage. \u3008http:\/\/www.wadaama.org\u3009. (Last accessed 17 June 2023)."},{"key":"10.1016\/j.jpba.2024.116007_bib22","unstructured":"World Anti-Doping Agency. WADA Technical Document TD2022MRPL. \u3008http:\/\/www.wadaama.org\u3009. (Last accessed 17 January 2023)."},{"key":"10.1016\/j.jpba.2024.116007_bib23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/dta.3254","article-title":"Feasibility of microvolumetric capillary whole blood collections for usage in Athletes Biological Passport analysis","volume":"14","author":"Goodrum","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/dta.3603","article-title":"Application of micro capillary blood sampling in an antidoping setting","author":"Lewis","year":"2023","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib25","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/dta.3030","article-title":"Stability and detectability of testosterone esters in dried blood spots after intramuscular injections","volume":"14","author":"Solheim","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jat\/32.7.511","article-title":"Stability of benzodiazepines and cocaine in blood spotd stored on filter paper","volume":"32","author":"Abdulkareem","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2024.116007_bib27","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.4155\/bio.13.121","article-title":"Stability of metabolites in dried blood spots stored at different temperatures over a 2-year period","volume":"5","author":"Prentice","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2024.116007_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jpba.2008.05.010","article-title":"Simultaneous determination of 17\u03b1-hydroxypregnenolone and 17\u03b1-hydroxyprogesterone in dried blood spots from low birth weight infants using LC\u2013MS\/MS","volume":"48","author":"Higashi","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116007_bib29","unstructured":"International Standard for Laboratories (ISL) | World Anti-Doping Agency. \u3008https:\/\/www.wada-ama.org\/en\/resources\/laboratories\/international-standard-for-laboratories-isl\u3009. Accessed 17 January 2023."},{"key":"10.1016\/j.jpba.2024.116007_bib30","unstructured":"World Anti-Doping Agency.WADA Technical Document TD2023IDCR. \u3008http:\/\/www.wada-ama.org\u3009. (Last accessed 17 January 2023)."},{"key":"10.1016\/j.jpba.2024.116007_bib31","unstructured":"ISO - ISO\/IEC 17025:2017 - General requirements for the competence of testing and calibration laboratories. \u3008https:\/\/www.iso.org\/standard\/66912.html\u3009. Accessed 17 January 2023."},{"key":"10.1016\/j.jpba.2024.116007_bib32","unstructured":"World Anti-Doping Agency. WADA Guidelines. Quantification of Endogenous Steroids in Blood for the Athlete Biological Passport. \u3008http:\/\/www.wada-ama.org\u3009. (Last accessed 17 Agust 2023)."},{"key":"10.1016\/j.jpba.2024.116007_bib33","unstructured":"World Anti-Doping Agency. WADA Guidelines. Analytical Requirements for the Endocrine Module of the Athlete Biological Passport. \u3008http:\/\/www.wada-ama.org\u3009. (Last accessed 17 Agust 2023)."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T17:41:06Z","timestamp":1715276466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"alternative-id":["S0731708524000475"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116007","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid vs dried blood matrices: Application to longitudinal monitoring of androstenedione, testosterone, and IGF-1 by LC\u2013MS-based techniques","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116007"}}